We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
-17.26%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.29B
AUM Growth
-$744M
Cap. Flow
+$126M
Cap. Flow %
3.81%
Top 10 Hldgs %
18.14%
Holding
1,378
New
105
Increased
487
Reduced
524
Closed
187

Top Sells

Rank Stock Value
1
TGT icon
Target
TGT
+$6.95M
2
NKE icon
Nike
NKE
+$5.91M
3
UNH icon
UnitedHealth
UNH
+$5.38M
4
EFA icon
iShares MSCI EAFE ETF
EFA
+$5.36M
5
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$4.93M

Sector Composition

Rank Sector Weight
1 Technology 16.51%
2 Healthcare 13.38%
3 Financials 10.48%
4 Consumer Discretionary 8.32%
5 Communication Services 7.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCHD icon
1026
Schwab US Dividend Equity ETF
SCHD
$107B
$205K 0.01%
13,704
WTM icon
1027
White Mountains Insurance
WTM
$5.04B
$205K 0.01%
225
FRTA
1028
DELISTED
Forterra, Inc
FRTA
$204K 0.01%
34,110
-973
-3% -$11.1K
AEE icon
1029
Ameren
AEE
$29.8B
$202K 0.01%
+2,777
New +$220K
INCY icon
1030
Incyte
INCY
$24.5B
$201K 0.01%
+2,750
New +$208K
KVHI icon
1031
KVH Industries
KVHI
$141M
$201K 0.01%
21,326
-18,460
-46% -$189K
SIRI icon
1032
SiriusXM
SIRI
$9.61B
$201K 0.01%
4,064
-1,510
-27% -$98.8K
VBR icon
1033
Vanguard Morningstar Small-Cap Value ETF
VBR
$38B
$201K 0.01%
2,268
-1,858
-45% -$225K
BANX
1034
ArrowMark Financial
BANX
$198M
$200K 0.01%
12,320
-2,474
-17% -$49.5K
FTF
1035
Franklin Limited Duration Income Trust
FTF
$234M
$199K 0.01%
25,383
+11,233
+79% +$101K
NAD icon
1036
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$199K 0.01%
14,538
+858
+6% +$12.4K
PCN
1037
PIMCO Corporate & Income Strategy Fund
PCN
$891M
$199K 0.01%
+14,950
New +$264K
OUT icon
1038
Outfront Media
OUT
$5.27B
$195K 0.01%
14,715
-627
-4% -$15.3K
CLDR
1039
DELISTED
Cloudera, Inc.
CLDR
$192K 0.01%
24,350
-36,650
-60% -$358K
JFR icon
1040
Nuveen Floating Rate Income Fund
JFR
$1.26B
$190K 0.01%
25,080
+43
+0.2% +$399
PGNX
1041
DELISTED
Progenics Pharmaceuticals Inc
PGNX
$190K 0.01%
50,000
CLB icon
1042
Core Laboratories
CLB
$570M
$188K 0.01%
18,132
-1,000
-5% -$28K
GNW icon
1043
Genworth Financial
GNW
$3.7B
$188K 0.01%
56,600
-2,000
-3% -$8.29K
BMY.RT
1044
DELISTED
Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT
$186K 0.01%
48,970
-4,913
-9% -$16.2K
DMO
1045
Western Asset Mortgage Opportunity Fund
DMO
$120M
$182K 0.01%
+14,194
New +$271K
EMD
1046
Western Asset Emerging Markets Debt Fund
EMD
$610M
$181K 0.01%
17,165
-141
-0.8% -$1.91K
SKT icon
1047
Tanger
SKT
$4.43B
$180K 0.01%
35,937
+19,021
+112% +$233K
BBK
1048
DELISTED
Blackrock Municipal Bond Trust
BBK
$180K 0.01%
+12,600
New +$192K
GAB icon
1049
Gabelli Equity Trust
GAB
$1.8B
$176K 0.01%
41,437
+1,678
+4% +$9.24K
PMO
1050
Franklin Municipal Opportunities Trust
PMO
$285M
$174K 0.01%
+14,585
New +$189K

Similar funds

Oppenheimer & Co's Q1 2020 Portfolio in Review

As of Q1 2020, Oppenheimer & Co held 1,378 positions worth $3.29B, down 18% from $4.04B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Oppenheimer & Co deployed $126M of net new capital in Q1 2020, opening 105 new positions and adding to 487 existing holdings. Its largest new stake was Hasbro: 50,954 shares worth $3.65M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Target, an estimated $6.95M trimmed.

  • Oppenheimer & Co's largest Q1 2020 buy was Hasbro: 50,954 shares worth $3.65M.
  • Oppenheimer & Co added most to Invesco QQQ Trust in Q1 2020, an estimated $24.5M increase.
  • Oppenheimer & Co's biggest Q1 2020 reduction was Target, cutting an estimated $6.95M.
  • Oppenheimer & Co fully exited Campbell Soup in Q1 2020, selling an estimated $3.76M.
  • Oppenheimer & Co's ten largest holdings make up 18% of its $3.29B portfolio in Q1 2020.
  • Oppenheimer & Co opened 105 new positions and closed 187 in Q1 2020.
  • Oppenheimer & Co's portfolio value fell 18% quarter-over-quarter to $3.29B.

Based on Oppenheimer & Co's 13F filing for Q1 2020, filed 8 May 2020.